A*Star
-
DATABASE (997)
-
ARTICLES (811)
CM International Financial Leasing Co. Ltd.
Founded in 2015, CM International Financial Leasing is a subsidiary of CMIG Leasing, with RMB 40 billion in assets.
Founded in 2015, CM International Financial Leasing is a subsidiary of CMIG Leasing, with RMB 40 billion in assets.
CEMEX Ventures is the investment arm of global Mexican cement giant CEMEX and was established in 2017 with offices in Mexico, Spain, Colombia and China. It focuses exclusively on tech and non-tech solutions to painpoints in the construction sector. Every year, together with global management consultant Boston Consulting Group and startup monitoring platform Tracxn, it names its 50 Most Promising Startups in the Construction Ecosystem, investing in a few of the companies cited. It currently has 12 companies in its portfolio.Its most recent investments have included an undisclosed contribution to the funding round of US soil marketplace Soil Connect in 4Q 2020 and in the $1.7m July 2020 Series A round of US recycling company Arqlite.
CEMEX Ventures is the investment arm of global Mexican cement giant CEMEX and was established in 2017 with offices in Mexico, Spain, Colombia and China. It focuses exclusively on tech and non-tech solutions to painpoints in the construction sector. Every year, together with global management consultant Boston Consulting Group and startup monitoring platform Tracxn, it names its 50 Most Promising Startups in the Construction Ecosystem, investing in a few of the companies cited. It currently has 12 companies in its portfolio.Its most recent investments have included an undisclosed contribution to the funding round of US soil marketplace Soil Connect in 4Q 2020 and in the $1.7m July 2020 Series A round of US recycling company Arqlite.
Bamboo Capital Partners is an impact investment company that focuses on supporting energy access, finance and healthcare-related ventures in developing countries. The company manages 10 investment funds across Asia, Africa, and Latin America, with companies in Indonesia, India, Kyrgyz Republic, and Brazil having received investments from this company. Bamboo Capital Partners states that their portfolio healthcare companies have served 3.4m patients, and 9.68m metric tons of CO2 emissions have been avoided through the use of solar panels and green energy championed by their startups.Bamboo Capital Partners have worked with governments and major investment groups to support the fulfillment of SDG goals through startup investing. In 2020, Bamboo Capital Partners was appointed by the government of Madagascar and the World Bank as the fund manager for the $40m Off-Grid Market Development Fund. Bamboo is also a partner of the Palladium Group, which owns a minority stake in the VC.
Bamboo Capital Partners is an impact investment company that focuses on supporting energy access, finance and healthcare-related ventures in developing countries. The company manages 10 investment funds across Asia, Africa, and Latin America, with companies in Indonesia, India, Kyrgyz Republic, and Brazil having received investments from this company. Bamboo Capital Partners states that their portfolio healthcare companies have served 3.4m patients, and 9.68m metric tons of CO2 emissions have been avoided through the use of solar panels and green energy championed by their startups.Bamboo Capital Partners have worked with governments and major investment groups to support the fulfillment of SDG goals through startup investing. In 2020, Bamboo Capital Partners was appointed by the government of Madagascar and the World Bank as the fund manager for the $40m Off-Grid Market Development Fund. Bamboo is also a partner of the Palladium Group, which owns a minority stake in the VC.
Investisseurs & Partenaires (I&P)
Set up in 2002 by Patrice Hoppenot 15 years after he founded European investment fund BC Partners, Investisseurs & Partenaires (I&P) is an impact investor seeking to help SMEs prosper in Africa and create sustainable jobs and income there. With about €210m raised to date, I&P finances SMEs, startups and regional investment funds in Africa through equity participation and loans, as well as through microfinance institutions. Its I&P Acceleration Technologies focuses on digital startups with €2.5m of funding to be invested in 10–15 startups in 2020–2023. To date, I&P has supported more than 100 capital-funded companies and 20 companies benefiting from subsidized acceleration programs. I&P has about 100 staff based in Paris, Washington D.C. and in seven African offices (Burkina Faso, Cameroon, Côte d'Ivoire, Ghana, Madagascar, Niger and Senegal).
Set up in 2002 by Patrice Hoppenot 15 years after he founded European investment fund BC Partners, Investisseurs & Partenaires (I&P) is an impact investor seeking to help SMEs prosper in Africa and create sustainable jobs and income there. With about €210m raised to date, I&P finances SMEs, startups and regional investment funds in Africa through equity participation and loans, as well as through microfinance institutions. Its I&P Acceleration Technologies focuses on digital startups with €2.5m of funding to be invested in 10–15 startups in 2020–2023. To date, I&P has supported more than 100 capital-funded companies and 20 companies benefiting from subsidized acceleration programs. I&P has about 100 staff based in Paris, Washington D.C. and in seven African offices (Burkina Faso, Cameroon, Côte d'Ivoire, Ghana, Madagascar, Niger and Senegal).
The British F1 racing driver and five-time FIA Formula One World Champion Lewis Hamilton has started to promote veganism and sustainable lifestyles, investing in several technology startups that develop solutions in that field.In 2019 he launched Neat Meat, the British vegan fast casual chain, in collaboration with The Cream Group, UNICEF Ambassadors and early investor in Beyond Meat Tommaso Chiabra. More recently he participated in a Series D funding round backing NotCo, the first Chilean unicorn selling plant-based food and beverage products across Latin America and the US.Hamilton is actively fighting to promote sustainable and eco-friendly practices across industries. In 2019 he also pushed Mercedes-Benz to discuss the possibility of including animal-free interiors in their cars. On that he said: I want to be part of a system that is going to help heal the world and do something positive for the future.”
The British F1 racing driver and five-time FIA Formula One World Champion Lewis Hamilton has started to promote veganism and sustainable lifestyles, investing in several technology startups that develop solutions in that field.In 2019 he launched Neat Meat, the British vegan fast casual chain, in collaboration with The Cream Group, UNICEF Ambassadors and early investor in Beyond Meat Tommaso Chiabra. More recently he participated in a Series D funding round backing NotCo, the first Chilean unicorn selling plant-based food and beverage products across Latin America and the US.Hamilton is actively fighting to promote sustainable and eco-friendly practices across industries. In 2019 he also pushed Mercedes-Benz to discuss the possibility of including animal-free interiors in their cars. On that he said: I want to be part of a system that is going to help heal the world and do something positive for the future.”
Roger Federer, the Swiss 20-times Grand Slam tennis champion, has turned into an angel investor while planning his professional life beyond and after his tennis sports career.In 2019, he invested in On, the Swiss running shoe manufacturer for an undisclosed funding amount. Federer currently has no formal role in the company but he’s actively involved in its R&D and product development. “I feel like I can give input on any of the lines, the shoes, anything moving forward. I can give my opinion on anything and On can either take it or leave it. I feel like [with] a major brand like Nike, that's literally impossible. It just wouldn't work,” he has said.More recently, Federer participated in a Series D funding round backing the first Chilean unicorn NotCo, which sells plant-based food and beverage products across Latin America and the US.
Roger Federer, the Swiss 20-times Grand Slam tennis champion, has turned into an angel investor while planning his professional life beyond and after his tennis sports career.In 2019, he invested in On, the Swiss running shoe manufacturer for an undisclosed funding amount. Federer currently has no formal role in the company but he’s actively involved in its R&D and product development. “I feel like I can give input on any of the lines, the shoes, anything moving forward. I can give my opinion on anything and On can either take it or leave it. I feel like [with] a major brand like Nike, that's literally impossible. It just wouldn't work,” he has said.More recently, Federer participated in a Series D funding round backing the first Chilean unicorn NotCo, which sells plant-based food and beverage products across Latin America and the US.
Established in 2011, Shilling Capital Partners is a Portuguese angel investment fund and one of the three subsidiaries of Mogope, a Portuguese investment manager, whose partners are also co-founders of Shilling. To date, the company has invested in 18 startups, both tech and bricks-and-mortar, and has managed three exits, including BestTables that was acquired by TripAdvisor. It typically invests between €250,000 and €1m in seed and Series A rounds and ensures liquidity until the next funding round, or when the startup becomes capable of funding its own growth. Recent investments include petcare marketplace Barkyn, healthy meal service delivery app EatTasty and blockchain-based online betting application BetProtocol.
Established in 2011, Shilling Capital Partners is a Portuguese angel investment fund and one of the three subsidiaries of Mogope, a Portuguese investment manager, whose partners are also co-founders of Shilling. To date, the company has invested in 18 startups, both tech and bricks-and-mortar, and has managed three exits, including BestTables that was acquired by TripAdvisor. It typically invests between €250,000 and €1m in seed and Series A rounds and ensures liquidity until the next funding round, or when the startup becomes capable of funding its own growth. Recent investments include petcare marketplace Barkyn, healthy meal service delivery app EatTasty and blockchain-based online betting application BetProtocol.
Castel Capital is a privately-owned Dutch venture capital and equity platform. The company also works with co-investors and private family offices to build bespoke investment portfolios. Castel focuses on both tech and non-tech business opportunities across Europe. Seed funding of €100,000–€500,000 and Series A rounds of €500,000–€1 million are generally available for tech deals. Castel has a hands-on management approach and seeks to add value to the portfolio companies. The firm has invested in 10 startups in diverse sectors like digital health, fintech and transportation.
Castel Capital is a privately-owned Dutch venture capital and equity platform. The company also works with co-investors and private family offices to build bespoke investment portfolios. Castel focuses on both tech and non-tech business opportunities across Europe. Seed funding of €100,000–€500,000 and Series A rounds of €500,000–€1 million are generally available for tech deals. Castel has a hands-on management approach and seeks to add value to the portfolio companies. The firm has invested in 10 startups in diverse sectors like digital health, fintech and transportation.
Iberis Capital is a Portuguese investor established in 2017. Currently with 10 investments with more than €100m under management, it invests in both tech and non-tech startups and in real estate. Iberis was founded by ex-partner at Oxy Capital Luís Quaresma and João Henriques, ex-CFO of Vodafone Portugal. One of its prominent portfolio companies is Australian medtech LBT Innovations that seeks to automate healthcare processes and, to date, has the only US Food and Drug Administration-cleared instrument leveraging AI in clinical microbiology. Its most recent investment was a participation in a €32m Series C investment round in December 2020 for Portugal-based international online print store, 360imprimir.
Iberis Capital is a Portuguese investor established in 2017. Currently with 10 investments with more than €100m under management, it invests in both tech and non-tech startups and in real estate. Iberis was founded by ex-partner at Oxy Capital Luís Quaresma and João Henriques, ex-CFO of Vodafone Portugal. One of its prominent portfolio companies is Australian medtech LBT Innovations that seeks to automate healthcare processes and, to date, has the only US Food and Drug Administration-cleared instrument leveraging AI in clinical microbiology. Its most recent investment was a participation in a €32m Series C investment round in December 2020 for Portugal-based international online print store, 360imprimir.
Founded in Chicago in 2011, Hyde Park invests in Midwestern US and occasionally Canadian startups from early-stage usually through two investment rounds across tech sectors. It currently has 62 startups in its portfolio and has managed 12 exits to date. Its most recent investments in January 2021 include Canadian e-commerce site BlackCart’s $8.8m Series A round and US podcast database Podchaser’s $5.7m Series A round. In November 2020, it invested in real estate productivity software NestEgg’s $7m Series A round.
Founded in Chicago in 2011, Hyde Park invests in Midwestern US and occasionally Canadian startups from early-stage usually through two investment rounds across tech sectors. It currently has 62 startups in its portfolio and has managed 12 exits to date. Its most recent investments in January 2021 include Canadian e-commerce site BlackCart’s $8.8m Series A round and US podcast database Podchaser’s $5.7m Series A round. In November 2020, it invested in real estate productivity software NestEgg’s $7m Series A round.
Since 2005, Demeter Partners has been one of the major VC and private equity funds supporting technology companies in developing solutions for ecological and energy transitions. The firm typically invests €1m–€30m in early and growth stages of startups. With assets worth over €1bn under management, its portfolio in 2019 was estimated to have cut 4.3m tons of CO2 with 575 GWh of clean energy produced. In 2021, Demeter was named the “Best Sustainable Equity investor” by a panel of former Fortune 500 individuals, global experts and industry leaders to recognize Demeter’s commitment to the UN’s SDG and ESG strategy.
Since 2005, Demeter Partners has been one of the major VC and private equity funds supporting technology companies in developing solutions for ecological and energy transitions. The firm typically invests €1m–€30m in early and growth stages of startups. With assets worth over €1bn under management, its portfolio in 2019 was estimated to have cut 4.3m tons of CO2 with 575 GWh of clean energy produced. In 2021, Demeter was named the “Best Sustainable Equity investor” by a panel of former Fortune 500 individuals, global experts and industry leaders to recognize Demeter’s commitment to the UN’s SDG and ESG strategy.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
Based in Berlin, Cherry Ventures was founded in 2012 to invest in startups across diverse sectors mainly in Europe including non-tech enterprises. With offices in London, Paris and Stockholm, the VC has invested in 53 startups and managed 12 exits. Initial investments range from €300,000 to €5m.In June 2019, a third fund “Cherry Ventures III” with €175m funding was launched to focus on providing seed funding for B2B and B2C startups. Recent investments in 2021 include the $6.2m seed round of Finnish cleantech Carbo Culture in April. The VC also acquired a stake in the $1.9m seed round of US Cloud-based product notification inbox, MagicBell, one of a handful of non-European startups in its portfolio.
Based in Berlin, Cherry Ventures was founded in 2012 to invest in startups across diverse sectors mainly in Europe including non-tech enterprises. With offices in London, Paris and Stockholm, the VC has invested in 53 startups and managed 12 exits. Initial investments range from €300,000 to €5m.In June 2019, a third fund “Cherry Ventures III” with €175m funding was launched to focus on providing seed funding for B2B and B2C startups. Recent investments in 2021 include the $6.2m seed round of Finnish cleantech Carbo Culture in April. The VC also acquired a stake in the $1.9m seed round of US Cloud-based product notification inbox, MagicBell, one of a handful of non-European startups in its portfolio.
Singapore's government-owned investor has a net portfolio value of just over S$300bn, with assets mainly in Asia and Singapore. In recent years it has begun investing in internet and tech companies in emerging markets, including in neighboring Indonesia and other Asian countries.As a state investor, Temasek aligns its investment portfolio and goals with areas that are relevant to Singapore’s national agenda. For example, to mitigate and reduce the effects of climate change, Temasek has set a commitment to reduce the carbon emissions of its portfolio companies, and invest in companies providing decarbonization solutions. It is also investing in biotechnology, medical technology, agritech and foodtech companies, which are some new focus areas in Singapore’s industrial development.
Singapore's government-owned investor has a net portfolio value of just over S$300bn, with assets mainly in Asia and Singapore. In recent years it has begun investing in internet and tech companies in emerging markets, including in neighboring Indonesia and other Asian countries.As a state investor, Temasek aligns its investment portfolio and goals with areas that are relevant to Singapore’s national agenda. For example, to mitigate and reduce the effects of climate change, Temasek has set a commitment to reduce the carbon emissions of its portfolio companies, and invest in companies providing decarbonization solutions. It is also investing in biotechnology, medical technology, agritech and foodtech companies, which are some new focus areas in Singapore’s industrial development.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
DGene : Star Wars-inspired 3D holograms made affordable for businesses
DGene's mobile-based VR/AR solution using integrated light field cuts the need for 3D modeling, useful for many sectors from retail marketing to conference calls
UBTECH: CES robotics star wants to bring humanoid robots to every family
UBTECH’s next-generation bipedal robot recently made an impressive global debut, and the startup’s founder has once again become the focus of attention
Enoc Armengol: The design and e-commerce 3.0 star inspired by Inspector Gadget
Also a serial entrepreneur, the Spaniard has created a trail of celebrated design products and startups from Singapore to Barcelona
Future Food Asia 2021 announces finalists for $100,000 prize
Ten startups from agrifood tech and cleantech sectors will pitch during the five-day conference, are also eligible for two more prizes from sponsors Cargill and Thai Wah
Digital Union: Fighting fake users in China's mobile app industry
The Beijing-based cybersecurity startup is helping developers spot fake app downloads, so their ad money don’t go to waste
Future Food Asia 2021: Two winners take home $100,000 each
Agrifood startups, corporations and investors urged to collaborate and take action, tackling challenges in nutrition and climate change
Quant Group makes personal loans safer, easier in China
Using big data and AI, Chinese fintech startup Quant Group simplifies and accelerates loan processing, and assures monetary security for financial institutions
Oceanium: Supporting sustainable seaweed farming
Scottish startup Oceanium has developed a proprietary biorefinery and processing model to create seaweed-based compostable materials, alt-protein ingredients and nutraceuticals for use across industry verticals
Plant-based eggs (Part II): The foodtech startups to watch
Here’s a shortlist of the foodtech startups to watch in the global vegan egg market
For your X-ray records, just check the cloud
A Chinese startup has built a digital medical image library on the cloud, bringing ease and cost savings to patients, doctors and hospitals countrywide
HighPitch: E-grocery marketplace Pasar20 and healthcare edtech Appskep top the Medan chapter
Representing Sumatra’s startup ecosystem in the national finals later in November, Pasar20 and Appskep have ambitious expansion plans in store
BukuWarung: Accounting-payments app targets Indonesia's 60m MSMEs
BukuWarung’s easy-to-use 6MB app designed for lower-end smartphones gets boost from Covid-19-accelerated digitalization
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
Inspired by rowdy teenagers: the Musical.ly story
Now better known as TikTok, the original Musical.ly was the only Chinese social app to have cracked the Western market – before it got snapped up by Bytedance and joined its stable of short video apps
Using Reworld’s very own interactive physics engine, even rookie developers can turn their creative ideas into 3D games within two days
Sorry, we couldn’t find any matches for“A*Star”.
POPULAR DATABASE
